MAINTENANCE OF FOREARM VASODILATOR ACTION OF ATRIAL-NATRIURETIC-FACTOR IN CONGESTIVE-HEART-FAILURE SECONDARY TO ISCHEMIC OR IDIOPATHIC DILATED CARDIOMYOPATHY

被引:12
作者
KUBO, SH
ATLAS, SA
LARAGH, JH
CODY, RJ
机构
[1] CORNELL UNIV,MED CTR,NEW YORK HOSP,DIV CARDIOL,NEW YORK,NY 10021
[2] CORNELL UNIV,MED CTR,NEW YORK HOSP,CTR HYPERTENS,DEPT MED,NEW YORK,NY 10021
关键词
D O I
10.1016/0002-9149(92)91226-T
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Infusions of atrial natriuretic factor (ANF) are frequently associated with attenuated natriuretic and diuretic responses in patients with congestive heart failure. However, ANF infusions result in systemic vasodilation, suggesting that end organ responsiveness to ANF may not be uniformly decreased. To determine if the vasodilator effects of ANF were altered in heart failure, strain-gauge plethysmography was utilized to measure forearm blood flow responses to the intraarterial infusion of ANF using a dose range that was low enough to avoid systemic effects. In 9 control subjects, ANF infusions of 0.5, 1.0, 2.0 and 4.0-mu-g/min/100 ml forearm volume significantly increased forearm blood flow from 3.21 +/- 1.71 to 5.69 +/- 3.14, 6.20 +/- 2.57, 6.64 +/- 2.53 and 6.97 +/- 2.49 ml/min/100 ml forearm volume, respectively (all p < 0.01). In 7 patients with heart failure, ANF infusion significantly increased forearm blood flow from 2.19 +/-0.98 to 3.18 +/- 1.70, 3.76 +/- 2.0 and 4.42 +/- 2.80 ml/min/100 ml forearm volume for the 0.5, 1.0 and 2.0-mu-g doses, respectively (all p < 0.05). By analysis of variance, the forearm blood flow responses pooled over all doses were not significantly different between the 2 groups. At the 2.0-mu-g dose, the peak increase in forearm blood flow in normal subjects represented a 107% increase over baseline compared with a 102% increase in patients with heart failure. In summary, these data demonstrate that intraarterial administration of ANF in patients with heart failure resulted in dose-related increases in forearm blood flow. The responses were not significantly different from normal subjects expressed both as an absolute response and as a percent increase. These data therefore confirm that rat ANF in pharmacologic doses has a direct vasodilator action in humans and further suggest that ANF-mediated vasodilation in the peripheral circulation is relatively intact in heart failure.
引用
收藏
页码:1306 / 1309
页数:4
相关论文
共 23 条
[1]   THE VASODILATOR POTENCY OF ATRIAL-NATRIURETIC-PEPTIDE IN MAN [J].
BOLLI, P ;
MULLER, FB ;
LINDER, L ;
RAINE, AEG ;
RESINK, TJ ;
ERNE, P ;
KIOWSKI, W ;
RITZ, R ;
BUHLER, FR .
CIRCULATION, 1987, 75 (01) :221-228
[2]  
BURNETT J C JR, 1988, Journal of the American College of Cardiology, V11, p239A
[3]   ATRIAL-NATRIURETIC-FACTOR IN NORMAL SUBJECTS AND HEART-FAILURE PATIENTS - PLASMA-LEVELS AND RENAL, HORMONAL, AND HEMODYNAMIC-RESPONSES TO PEPTIDE INFUSION [J].
CODY, RJ ;
ATLAS, SA ;
LARAGH, JH ;
KUBO, SH ;
COVIT, AB ;
RYMAN, KS ;
SHAKNOVICH, A ;
PONDOLFINO, K ;
CLARK, M ;
CAMARGO, MJF ;
SCARBOROUGH, RM ;
LEWICKI, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) :1362-1374
[4]   IDENTIFICATION OF THE DIRECT VASODILATOR EFFECT OF MILRINONE WITH AN ISOLATED LIMB PREPARATION IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE [J].
CODY, RJ ;
MULLER, FB ;
KUBO, SH ;
RUTMAN, H ;
LEONARD, D .
CIRCULATION, 1986, 73 (01) :124-129
[5]   LIMB VASCULAR RESPONSIVENESS TO BETA-ADRENERGIC-RECEPTOR STIMULATION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
CREAGER, MA ;
QUIGG, RJ ;
REN, CJ ;
RODDY, MA ;
COLUCCI, WS .
CIRCULATION, 1991, 83 (06) :1873-1879
[6]   THE AMINO-ACID-SEQUENCE OF AN ATRIAL PEPTIDE WITH POTENT DIURETIC AND NATRIURETIC PROPERTIES [J].
FLYNN, TG ;
DEBOLD, ML ;
DEBOLD, AJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 117 (03) :859-865
[7]  
GRUETTER CA, 1981, J PHARMACOL EXP THER, V219, P181
[8]   ATTENUATED FOREARM VASODILATIVE RESPONSE TO INTRAARTERIAL ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH HEART-FAILURE [J].
HIROOKA, Y ;
TAKESHITA, A ;
IMAIZUMI, T ;
SUZUKI, S ;
YOSHIDA, M ;
ANDO, S ;
NAKAMURA, M .
CIRCULATION, 1990, 82 (01) :147-153
[9]   ENHANCED VASODILATATION IN ESSENTIAL-HYPERTENSION BY CALCIUM-CHANNEL BLOCKADE WITH VERAPAMIL [J].
HULTHEN, UL ;
BOLLI, P ;
AMANN, FW ;
KIOWSKI, W ;
BUHLER, FR .
HYPERTENSION, 1982, 4 (03) :26-31
[10]   ENDOTHELIUM-DEPENDENT VASODILATION IS ATTENUATED IN PATIENTS WITH HEART-FAILURE [J].
KUBO, SH ;
RECTOR, TS ;
BANK, AJ ;
WILLIAMS, RE ;
HEIFETZ, SM .
CIRCULATION, 1991, 84 (04) :1589-1596